Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Pancreatic Cancer Drug Pipeline Report'
Title Publication Date Price Relevance
Pancreatic Cancer Drug Pipeline Update 2009 Jan 2009 £1,245 100%
Pancreatic Cancer Drug Pipeline Update 2011 Feb 2011 £1,245 99%
Triple Analysis: Leukemia, Melanoma and Pancreatic Cancer Nov 2010 £2,865 99%
Triple Analysis: Breast Cancer, Leukemia and Pancreatic Cancer Apr 2010 £2,865 99%
Pancreatic Cancer - Pipeline Review
H2 2011
 Nov 2011 £315 99%
Metastatic Pancreatic Cancer - Pipeline Review
H1 2012
 Jan 2012 £325 99%
Triple Analysis: Lymphoma, Melanoma and Pancreatic Cancer May 2011 £2,865 99%
Triple Analysis: Leukemia, Melanoma and Pancreatic Cancer Apr 2011 £2,865 99%
Triple Analysis: Leukemia, Lymphoma and Pancreatic Cancer May 2011 £2,865 99%
Triple Analysis: Leukemia, Pancreatic Cancer and Angiogenesis Apr 2011 £2,865 99%
Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer May 2011 £2,865 99%
Triple Analysis: Breast Cancer, Melanoma and Pancreatic Cancer Nov 2010 £2,865 99%
Triple Analysis: Breast Cancer, Lymphoma and Pancreatic Cancer May 2011 £2,865 99%
Triple Analysis: Breast Cancer, Leukemia and Pancreatic Cancer Apr 2011 £2,865 99%
Triple Analysis: Melanoma, Pancreatic Cancer and Angiogenesis Jan 2012 £2,865 99%
Triple Analysis: Melanoma, Pancreatic Cancer and Peptides Nov 2011 £2,865 99%
Triple Analysis: Lymphoma, Pancreatic Cancer and Angiogenesis Jan 2012 £2,865 99%
Triple Analysis: Lung Cancer, Melanoma and Pancreatic Cancer Jul 2011 £2,865 99%
Triple Analysis: Leukemia, Pancreatic Cancer and Angiogenesis Jan 2012 £2,865 99%
Triple Analysis: Lymphoma, Pancreatic Cancer and Peptides Nov 2011 £2,865 99%
Triple Analysis: Leukemia, Pancreatic Cancer and Peptides Nov 2011 £2,865 99%
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Angiogenesis Jan 2012 £2,865 99%
Triple Analysis: Lung Cancer, Lymphoma and Pancreatic Cancer Jul 2011 £2,865 99%
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Peptides Nov 2011 £2,865 99%
Triple Analysis: Breast Cancer, Pancreatic Cancer and Angiogenesis Jan 2012 £2,865 99%
Triple Analysis: Melanoma, Pancreatic Cancer and Apoptosis Dec 2011 £2,865 99%
Triple Analysis: Leukemia, Lung Cancer and Pancreatic Cancer Jul 2011 £2,865 99%
Triple Analysis: Melanoma, Pancreatic Cancer and Cancer Vaccines Nov 2010 £2,865 99%
Triple Analysis: Breast Cancer, Pancreatic Cancer and Peptides Nov 2011 £2,865 99%
Triple Analysis: Lymphoma, Pancreatic Cancer and Cancer Vaccines May 2011 £2,865 99%